VANCOUVER, July 20, 2017 /CNW/ - Isodiol International Inc.
(CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the "Company" or "Isodiol") a global cannabis innovator specializing in
the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy
Growth Corporation ("Canopy") (TSX:WEED) (https://www.canopygrowth.com).
Canopy Growth is the world's premier cannabis company that operates a collection of diverse brands and curated strain
varieties, supported by over half a million square feet of indoor and greenhouse production capacity. Under this licensing
agreement, Canopy Growth will have the right to manufacture and distribute the Company's "Pot-O-Coffee" and "Pot-O-Tea" branded
marijuana infused single serve K-Cup products in Canada and certain other markets
internationally as federal regulations allow. Licensed products include caffeinated and de-caffeinated product lines as
well as Isodiol's single serve "Pot-O-Coco". In addition to the Canadian rights, Canopy Growth shall have the right of
first refusal to sell the "Pot-O" brand products in any territory outside of the US, Mexico and
Puerto Rico.
"This distribution agreement has us positioned to increase our global footprint with the largest cannabis company in the
world. We will continue to develop our Pot-O-Coffee product lines with ready to drink and cold brew products while working
with Canopy Growth for international distribution channels. The Pot-O-Coffee brand is well recognized, and adding
additional products to this line will continue to strengthen its market presence," stated Isodiol's CEO Marcos Agramont.
The availability of the various licensed products in Canada and elsewhere will differ
depending on applicable laws and regulation. While Canadian law does not yet permit the manufacture and sale of marijuana
infused products, the Company anticipates that such products will be permitted in the near future. Furthermore, currently
proposed regulations which would permit the sale of infused products, would not allow such products to contain both marijuana and
caffeine. As such, the specific product offerings in Canada and elsewhere may be limited.
The Company will provide additional updates as regulations are adopted and as product roll-out plans are developed.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in
manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for
Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest
quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures
and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into
Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
" Marcos Agramont"
CEO & Director
Join Us On Facebook:
https://www.facebook.com/isodiol/
Twitter: @isodiol
Forward-Looking Information: This news release contains "forward-looking information"
within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future the
Company's business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations
reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be
correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are
subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those
contemplated by these statements depending on, among other things, the risks that the Company's products and plan will vary from
those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required
by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or
forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward
looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no
reference to profitability based on sales reported. The statements in this news release are made as of the date of this
release.
The CSE has not reviewed, approved or disapproved the content of this press release.
SOURCE Isodiol International Inc.
View original content: http://www.newswire.ca/en/releases/archive/July2017/20/c1583.html